Residual dizziness of benign paroxysmal positional vertigo
Conditions
Interventions
Test group:traditional Chinese medicine
control group:Betahistine Mesylate
Sponsors
BeijingHuairouHospitalofTraditionalChineseMedicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for BPPV in Western medicine; Meets the diagnostic criteria for dizziness in traditional Chinese medicine; Meets the diagnostic criteria of traditional Chinese medicine syndrome. 2) Meets the diagnostic criteria for residual dizziness after manual reduction of benign paroxysmal positional vertigo; 3) Age between 18-80 years old male or female not limited; 4) Voluntarily participate in this experiment and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Secondary benign paroxysmal positional vertigo (s-BPPV) with a clear etiology. 2) Dizziness caused by Meniere's disease vestibular neuron inflammation cerebellar infarction brain tumors traumatic brain injury cerebral hemorrhage and certain autonomic nervous system diseases such as Parkinson's disease (PD) multiple system atrophy and other reasons; 3) Merge patients with other serious diseases such as lung heart liver kidney and blood disorders; 4) Patients with severe combined liver and kidney dysfunction (note: Liver dysfunction refers to ALT or AST values greater than twice the normal upper limit; Renal insufficiency refers to a blood creatinine level greater than twice the upper limit of normal; 5) Patients with severe cognitive impairment or serious mental illnesses; 6) Patients who are taking drugs that affect the autonomic nervous system such as anticholinergic drugs beta receptor antagonists and drugs that affect HCY UA NLR and PLR observation indicators; 7) Patients who are allergic to the ingredients in our formula; 8) Pregnant or lactating women; 9) Participants in clinical trials of other drugs. 10) Those who cannot and/or are unwilling to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of residual dizziness; | — |
Secondary
| Measure | Time frame |
|---|---|
| uric acid;platelet-lymphocyte ratio,PLR;dizziness handicap inventory;Dizziness Visual Analog Scale; Homocysteine;Score of Traditional Chinese Medicine Dizziness Grading Scale;neutrophil-lymphocyte ratio,NLR; | — |
Countries
China
Contacts
Public ContactHao Shanshan
BeijingHuairouHospitalofTraditionalChineseMedicine
Outcome results
None listed